Business Description
Sibanye Stillwater Limited, along with its various subsidiaries, functions as a prominent precious metals mining entity with operations spanning South Africa, the United States, Zimbabwe, Canada, and Argentina. The company's primary outputs encompass gold and Platinum Group Metals (PGMs) – specifically palladium, platinum, and rhodium – alongside secondary commodities such as iridium, ruthenium, nickel, copper, and chrome. In the United States, its assets include the East Boulder and Stillwater mines situated in Montana. These are supported by the Columbus metallurgical complex, which is responsible for smelting the mined material into PGM-rich filter cake and also conducts PGM recycling activities. Its extensive portfolio in South Africa features PGM operations at Kroondal, Rustenburg, Marikana, and Platinum Mile. Gold production stems from surface facilities like Driefontein, Kloof, and Cooke, located on the West Rand of the Witwatersrand Basin, as well as the Beatrix mine in the southern Free State. Further international interests include the Mimosa mine in the southern region of Zimbabwe, the Marathon PGM project in Ontario, Canada, and the Altar and Rio Grande copper-gold ventures nestled within the Andes in northwest Argentina. Sibanye Stillwater also maintains holdings in surface tailings retreatment facilities and other South African gold projects, including Hoedspruit, Burnstone, and additional sites in the southern Free State. The company was founded in 2013 and maintains its headquarters in Weltevreden Park, South Africa.
Business History
Generated: Jun 3, 2026 7:16pmPrice Overview
Last updated: Jun 27, 2026 8:01am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -6.80
Total Equity: $39.49B
Shares: 707,641,750
Total Debt: $43.26B
Cash: $17.16B
EBITDA: $19.39B
Total Debt: $43.26B
Cash: $17.16B
Revenue: $120.10B
Shares: 707,641,750
Revenue: $120.10B
Revenue: $120.10B
Revenue: $120.10B
Total Equity: $39.49B
Tax Rate: -1,053.0%
Equity: $39.49B
Total Debt: $43.26B
Cash: $17.16B
Current Liabilities: $34.12B
Long-Term Debt: $31.86B
Total Debt: $43.26B
Total Equity: $39.49B
Shares: 707,641,750
Shares: 707,641,750
CapEx: -$18.81B
Shares: 707,641,750
Stock Price: $8.87
Net Income: -$4.79B
Industry Benchmarks
Advanced Analysis Forensic deep-dive · three lenses
The trajectory tells the real story the modules gloss over: revenue collapsed from $172B (2021) to $112B (2024) as PGM prices broke, gross margin compressed from 34.9% to 5.6%, and the company printed cumulative net losses of roughly $49.9B across 2023-2024 with two years of double-digit-billion negative FCF ($-15.3B then $-11.3B). 2025 is a genuine inflection — revenue $120.1B, GM back to 23.8%, OpM 18.5%, FCF +$1.69B — but it follows a balance-sheet hit that left net debt at $26.7B against a $7.85B market cap. The 'cash/mktcap 218.6%' headline from the liquidity module is misleading because net cash is deeply negative; this is a levered cyclical, not a cash fortress.
Earnings quality is genuinely mixed-to-poor: OCF/NI at -0.81x and accruals at -11.8% of assets look weird because net income is still negative while cash flow recovered — the ratios are distorted by the loss. Beneish M of -5.31 is clean (no manipulation signal), but Altman Z of 1.37 sits squarely in the distress zone, which for an asset-heavy SA miner is a real flag, not a model artifact. Share count is genuinely flat-to-shrinking (-0.8% CAGR), SBC is negligible — no per-share erosion here, which is the one unambiguous positive on the structural side.
The insider tape is the most interesting non-obvious tell: 6 separate P-purchases clustered in a tight window (March 20-31, 2026), including a $1.7M buy by Keyter and meaningful buys from Maphai, Carter, Nkosi, Menell — multiple names, open-market, real money. That is a cluster, not a token gesture, and it lines up with the FCF inflection. Against this: AI synthesis flags 'missing debt disclosure,' the valuation is 'disconnected from fundamentals,' and the business remains a price-taker on PGMs with SA jurisdictional risk. Fair value $14-16 vs $11.10 is a ~25-40% gap — real, but not screaming.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 22, 2026 7:45am (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $172.2B | $138.3B | $113.7B | $112.1B | $120.1B |
| Cost of Revenue | $112.0B | $103.5B | $100.9B | $105.8B | $91.5B |
| Gross Profit | $60.2B | $34.8B | $12.8B | $6.3B | $28.6B |
| Operating Expenses | $395.0M | $608.0M | $4.4B | $2.6B | $2.1B |
| Operating Income | $62.5B | $36.4B | $13.6B | $3.7B | $39.1B |
| Net Income | $33.1B | $18.4B | -$37.8B | -$7.3B | -$4.8B |
| EBITDA | $57.6B | $37.1B | -$27.5B | $164.0M | $19.4B |
| EPS | $45.60 | $26.04 | $-53.36 | $-10.32 | $-6.80 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 22, 2026 7:45am (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $30.3B | $26.1B | $25.6B | $16.0B | $17.2B |
| Total Current Assets | $64.8B | $60.8B | $61.8B | $48.4B | $60.7B |
| Total Assets | $153.0B | $166.6B | $142.9B | $138.0B | $149.6B |
| Current Liabilities | $20.5B | $20.2B | $36.4B | $20.9B | $34.1B |
| Long-Term Debt | $20.2B | $22.6B | $24.9B | $41.1B | $31.9B |
| Total Liabilities | $71.6B | $75.6B | $91.3B | $89.7B | $105.5B |
| Total Equity | $79.4B | $91.0B | $48.7B | $44.0B | $39.5B |
| Retained Earnings | $27.4B | $33.8B | -$8.5B | -$13.8B | -$19.1B |
Cash Flow (Annual)
Last updated: Jun 22, 2026 7:45am (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $32.3B | $15.5B | $7.1B | $10.3B | $20.5B |
| Capital Expenditure | -$12.7B | -$15.9B | -$22.4B | -$21.6B | -$18.8B |
| Free Cash Flow | $19.5B | -$356.0M | -$15.3B | -$11.3B | $1.7B |
| Acquisitions (net) | -$998.0M | -$1.4B | $471.0M | -$3.0B | -$1.7B |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$8.5B | $0 | $0 | $0 | $0 |
| Net Change in Cash | $10.1B | -$4.2B | -$516.0M | -$9.5B | $3.1B |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 8:01am (just now)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$177.8B $159.8B – $207.0B
|
$162.5B $145.8B – $187.9B
|
$140.8B $126.3B – $162.8B
|
$174.4B $156.4B – $201.6B
|
| EBITDA |
$18.2B $16.4B – $21.2B
|
$16.6B $14.9B – $19.2B
|
$14.4B $12.9B – $16.7B
|
$17.9B $16.0B – $20.6B
|
| Net Income |
$26.7B $23.1B – $32.1B
|
$24.1B $20.9B – $29.0B
|
$18.6B $16.1B – $22.4B
|
$35.7B $30.9B – $42.9B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 22, 2026 7:45am (5d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | -19.7% | -17.8% | -1.4% | +7.1% |
| Gross Profit Growth | -42.1% | -63.3% | -50.7% | +353.7% |
| Operating Income Growth | -41.7% | -62.6% | -73.0% | +961.9% |
| Net Income Growth | -44.3% | -305.3% | +80.7% | +34.4% |
| EBITDA Growth | -35.6% | -174.1% | +100.6% | +11,722.0% |
Insider Trading (Recent)
All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-03-31 | Nkosi Themba George | P-Purchase | 11,865.00 | $2.91 | $34,527 |
| 2026-03-30 | Carter Charles Edward | P-Purchase | 10,000.00 | $11.40 | $114,000 |
| 2026-03-23 | Keyter Charl | P-Purchase | 35,000.00 | $2.70 | $94,500 |
| 2026-03-24 | Menell Richard Peter | P-Purchase | 2,500.00 | $11.43 | $28,575 |
| 2026-03-20 | Keyter Charl | P-Purchase | 148,819.00 | $11.63 | $1.7M |
| 2026-03-16 | Maphai Thabane Vincent | P-Purchase | 12,000.00 | $13.34 | $160,080 |
| 2026-03-18 | Boisseau Philippe | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Nkosi Themba George | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Nkosi Themba George | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Hancock Peter James | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Naidoo-Vermaak Melanie | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Doward-King Elaine Jay | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Bhulose Mduduzi Cyril | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Mthimunye Lindiwe | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Cumming Timothy | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Menell Richard Peter | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Cox Richard Allen | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Rayner Keith Alfred | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Rayner Keith Alfred | 0.00 | $0.00 | $0 | |
| 2026-03-17 | Seitovirta Mika Ilkka | 0.00 | $0.00 | $0 |
Dividend History (Last 20)
Last updated: Jun 22, 2026 7:45am (5d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-03-20 | $0.31 | 2026-02-20 | 2026-03-20 | 2026-04-02 |
| 2023-09-21 | $0.11 | 2023-09-05 | 2023-09-22 | 2023-10-06 |
| 2023-03-23 | $0.27 | 2023-02-28 | 2023-03-24 | 2023-04-06 |
| 2022-09-15 | $0.32 | 2022-08-30 | 2022-09-16 | 2022-09-29 |
| 2022-03-24 | $0.41 | 2022-03-09 | 2022-03-25 | 2022-04-07 |
| 2021-09-16 | $0.63 | 2021-09-02 | 2021-09-17 | 2021-09-30 |
| 2021-03-18 | $0.86 | 2021-02-22 | 2021-03-19 | 2021-04-01 |
| 2020-09-17 | $0.10 | 2020-08-28 | 2020-09-18 | 2020-10-01 |
| 2017-04-05 | $0.18 | 2017-04-07 | 2017-04-20 | |
| 2016-09-21 | $0.23 | |||
| 2016-03-16 | $0.23 | |||
| 2015-09-02 | $0.03 | |||
| 2015-03-18 | $0.21 | |||
| 2014-08-20 | $0.18 | |||
| 2014-03-12 | $0.27 | |||
| 2013-10-02 | $0.15 |
Narrative Economics
market-narrative step).
Delvantic AI Findings
The raw numbers tell a less catastrophic story than the synthesis models suggest, but also a messier one. Revenue in 2025 was R120.1B versus R112.1B in 2024 — modest 7% growth — and gross profit recovered violently from R6.3B to R28.6B, a 354% jump that the synthesis layer barely acknowledges. Operating cash flow of R20.5B is real and the company ended with R17.2B cash. But free cash flow was only R1.7B because capex ate R18.8B — that's not a company harvesting, it's one still feeding capital into shafts. The quarterly trajectory is also not "accelerating" in any clean sense: Q4 2025 revenue of R71.4B vs Q2 2025's R54.8B reflects seasonality and PGM basket price moves, not operational momentum, and net income is still negative (-R1.5B in Q4, -R3.6B in Q2). The "Good Revenue Confidence – accelerating" tag from the secondary signals layer is misleading; this is commodity price beta, not demand acceleration.
I dissent from the synthesis verdict of "Disconnected from Fundamentals / value trap." That framing leans too hard on the EV/palladium-destruction narrative the pre-flight model itself flagged as already priced in. At $11.10 and a $7.85B market cap, EV/EBITDA of 6.6x is not a distressed multiple for a PGM+gold producer where gold is at all-time highs and platinum has rallied ~40% YTD in 2025. The ROIC of 23.9% (TTM) sits oddly next to the "headwinds" narrative — even discounting the TTM-window caveat, that's not the signature of structural unprofitability. The classification engine calling this "pre_profit_growth" is simply wrong; this is a cyclical commodity producer, and the pre-flight layer correctly overrode it. The market-forces model's "heroic commodity price assumptions" critique is stale — palladium doesn't need to return to $1,500 for SBSW to work; the gold half (Stillwater is the PGM drag, not the SA gold ops) is printing money at $2,600+ gold.
The contrarian case against my own pushback: capex of R18.8B against R20.5B OCF means FCF conversion is genuinely poor, and the missing balance sheet debt figure is a real gap — Sibanye carried roughly R30B+ in debt historically, and at a 4.2x P/B with negative ROE -12.9%, equity is being eroded. The 2023 -R45B and 2024 -R7.3B losses impaired book substantially. Insider buying in March 2026 is the most interesting signal in the file — six separate purchases including a 148,819-share block — but the "?" insider name field is a data quality red flag I can't verify is C-suite vs. a 10b5-1 plan or a director's token buy. Treat it as supportive, not decisive. The dividend yield collapsing to 0.17% from the 2021-22 super-cycle highs tells you management itself doesn't trust the cash flow durability.
Net: the synthesis and market-forces models are anchored to a 2023-2024 distressed narrative that the 2025 numbers have partially invalidated, while the momentum layer is overstating a price-driven revenue bump as acceleration. Truth is in between. At $11.10, you're paying 1.4x sales and 6.6x EV/EBITDA for a producer with leverage to gold (working) and PGMs (recovering off a bottom), with insiders buying and OCF inflecting positive. That's not a value trap — it's an under-owned cyclical with a credible 12-18 month re-rating path if PGM basket prices hold. But the negative quarterly NI prints, capex intensity, and missing debt disclosure mean this isn't a fat-pitch either. Fair value in a normalized-margin scenario (gross margin reverting to 30%, FCF conversion improving to 30% of OCF) supports $14-16; downside to $7-8 if palladium breaks $700 and SA labor disruption returns. Risk/reward is roughly 2:1 to the upside from here, not the 5:1 a true distressed-to-recovery setup would offer.
GPT Critique
Sibanye Stillwater's financials present a complex picture of a cyclical commodity producer grappling with both challenges and opportunities. The revenue trajectory from 2024 to 2025 reflects a modest growth of 7%, but the more striking figure is the gross profit recovery from $6.31B to $28.61B. This suggests a significant margin rebound, likely driven by favorable commodity price movements rather than operational improvements. The operating cash flow of $20.49B juxtaposed with the low free cash flow of $1.69B highlights the company's heavy capital expenditure of $18.81B, indicating ongoing investment in production capabilities rather than a focus on harvesting profits. The negative net income across several quarters, including a substantial loss of $45.20B in 2023, underscores the operational and market volatility the company faces.
I partially agree with Opus's assessment that the narrative of Sibanye being a "value trap" is overemphasized. The EV/EBITDA ratio of 6.6x, in the context of a commodity producer with exposure to both gold and PGMs, does not scream distress, especially when gold prices have maintained strength. Opus's point that the ROIC of 23.9% challenges the notion of structural unprofitability is valid, although I remain cautious given the variability in commodity cycles. Additionally, the insider purchases, despite the data quality issues, suggest internal confidence, aligning with Opus's view that they are a positive signal.
However, I diverge from Opus's conclusion that the market's focus on a 2023-2024 distressed narrative is outdated. The persistent negative net income and the erosion of equity, reflected in a negative ROE of -12.9%, cannot be ignored. The capex intensity alongside missing debt figures introduces considerable uncertainty about the company's financial health and strategic path forward. Furthermore, while Opus suggests that the palladium price does not need to hit $1,500 for Sibanye to perform, the volatile nature of PGM prices and geopolitical factors in regions like South Africa introduce risks that could impact future cash flows and margins.
A skeptic might argue that both Opus and I are underestimating the potential for continued operational disruptions and geopolitical instability to erode margins further. They would highlight the significant capex as a potential drag on free cash flow, constraining the company's ability to weather commodity price downturns. Additionally, the lack of clear debt disclosure could mask leverage risks, making the stock less appealing under current market conditions.